Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 4 | 4 | 2 | 14 |
| Accounts receivable | N/A | 0 | 168 | -775 | 215 |
| Accounts payable and accrued liabilities | 1,216 | 2,799 | 2,964 | -298 | 931 |
| Other Working Capital | 1,627 | 2,669 | 3,946 | -1,024 | 1,098 |
| Other Operating Activity | -4,657 | -14,963 | -14,776 | -3,374 | -3,969 |
| Operating Cash Flow | $-1,811 | $-9,491 | $-7,695 | $-5,468 | $-1,711 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | 0 | -6 | -2 | -7 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -12 |
| Investing Cash Flow | $-1 | $0 | $-6 | $-2 | $-19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 950 | 0 | 2,000 | 0 | 8,078 |
| Debt Repayment | N/A | N/A | 0 | 0 | -14 |
| Common Stock Issued | 1,706 | 6,209 | 7,323 | 0 | 249 |
| Other Financing Activity | 0 | 0 | 0 | 2,153 | 17 |
| Financing Cash Flow | $2,656 | $6,209 | $9,323 | $2,153 | $8,330 |
| Exchange Rate Effect | -110 | 63 | -278 | -872 | N/A |
| Beginning Cash Position | 827 | 4,045 | 2,701 | 6,889 | 261 |
| End Cash Position | 1,561 | 827 | 4,045 | 2,701 | 6,861 |
| Net Cash Flow | $844 | $-3,282 | $1,622 | $-3,316 | $6,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,811 | -9,491 | -7,695 | -5,468 | -1,711 |
| Capital Expenditure | -1 | N/A | -6 | -2 | -7 |
| Free Cash Flow | -1,812 | -9,491 | -7,701 | -5,470 | -1,718 |